Ageing well: becoming a world leader in tackling dementia and Alzheimer’s
Best of the Spectator
00:00
Challenges and Opportunities in UK Life Sciences
The chapter delves into the challenges faced by the UK in advancing its competitiveness in life sciences, particularly in conducting clinical trials for therapeutics in the post-COVID era. It emphasizes the accelerated research efforts in dementia and Alzheimer's disease due to the pandemic's impact, underlining the need for faster trials and increased funding to address critical issues in the field.
Transcript
Play full episode
